ALLSCRIPTS HEALTHCARE SOLUTN's ticker is and the CUSIP is 01988PAD0. A total of 35 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,854,000 | +108.0% | 11,268,000 | +114.3% | 0.30% | +211.2% |
| Q4 2019 | $5,219,000 | -79.2% | 5,259,000 | -79.7% | 0.10% | -57.2% |
| Q4 2018 | $25,096,000 | +58.6% | 25,970,000 | +73.1% | 0.23% | +7.5% |
| Q3 2018 | $15,824,000 | -2.0% | 15,000,000 | -6.4% | 0.21% | -16.8% |
| Q1 2018 | $16,145,000 | -57.3% | 16,033,000 | -54.5% | 0.26% | -56.8% |
| Q4 2017 | $37,809,000 | +20.1% | 35,233,000 | +19.5% | 0.59% | +26.2% |
| Q3 2017 | $31,494,000 | +315.5% | 29,488,000 | +268.2% | 0.47% | +319.6% |
| Q4 2016 | $7,579,000 | -68.0% | 8,008,000 | -65.3% | 0.11% | -63.5% |
| Q3 2016 | $23,689,000 | -23.5% | 23,058,000 | -24.9% | 0.31% | -44.9% |
| Q2 2016 | $30,960,000 | -5.1% | 30,708,000 | -4.2% | 0.56% | -4.9% |
| Q1 2016 | $32,630,000 | -13.8% | 32,065,000 | -7.8% | 0.59% | +17.2% |
| Q4 2015 | $37,846,000 | +6.7% | 34,785,000 | -2.8% | 0.50% | +7.5% |
| Q3 2015 | $35,465,000 | +271.1% | 35,785,000 | +287.5% | 0.46% | +318.9% |
| Q2 2015 | $9,557,000 | -17.3% | 9,235,000 | -21.3% | 0.11% | -9.0% |
| Q1 2015 | $11,561,000 | -82.3% | 11,735,000 | -82.1% | 0.12% | -82.5% |
| Q4 2014 | $65,284,000 | -13.0% | 65,735,000 | -10.9% | 0.70% | -43.8% |
| Q3 2014 | $75,022,000 | – | 73,785,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 15,000,000 | $14,775,000 | 1.84% |
| Sage Capital Management, LLC | 1,480,000 | $1,459,000 | 1.57% |
| Polar Asset Management Partners Inc. | 25,000,000 | $24,772,000 | 1.32% |
| PRICE MICHAEL F | 477,500 | $6,098,000 | 0.74% |
| OAKTREE CAPITAL MANAGEMENT LP | 65,735,000 | $65,284,000 | 0.70% |
| Jabre Capital Partners S.A. | 5,000,000 | $4,945,000 | 0.51% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 34,090,000 | $33,651,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 13,000,000 | $12,795,000 | 0.46% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 750,000 | $742,000 | 0.29% |
| BlueCrest Capital Management Ltd | 6,151,000 | $8,108,000 | 0.26% |